Davidson B
Division of Pathology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
Cytopathology. 2011 Feb;22(1):5-21. doi: 10.1111/j.1365-2303.2010.00829.x. Epub 2010 Nov 30.
Malignant mesothelioma and ovarian/peritoneal serous carcinoma are two of the most common tumours affecting the serosal cavities. Unlike other malignant tumours diagnosed at this anatomical site, such as lung and breast carcinoma, malignant mesothelioma and serous carcinoma share a common histogenesis, may be difficult to differentiate morphologically, and co-express many of the diagnostic markers used by cytopathologists in effusion diagnosis. Selected markers have nevertheless shown sufficient sensitivity and specificity to differentiate serous carcinoma from malignant mesothelioma effectively. Recently, our group applied high throughput technology to the identification of new markers that may aid in differentiating these two cancer types and validated several of these markers in follow-up studies. This review will present current data regarding the diagnostic and biological aspects of malignant mesothelioma and ovarian/peritoneal serous carcinoma.
恶性间皮瘤和卵巢/腹膜浆液性癌是影响浆膜腔的两种最常见肿瘤。与在此解剖部位诊断出的其他恶性肿瘤(如肺癌和乳腺癌)不同,恶性间皮瘤和浆液性癌具有共同的组织发生学,在形态学上可能难以区分,并且共同表达细胞病理学家在积液诊断中使用的许多诊断标志物。然而,选定的标志物已显示出足够的敏感性和特异性,可有效区分浆液性癌和恶性间皮瘤。最近,我们小组将高通量技术应用于新标志物的鉴定,这些标志物可能有助于区分这两种癌症类型,并在后续研究中验证了其中几种标志物。本综述将介绍有关恶性间皮瘤和卵巢/腹膜浆液性癌诊断和生物学方面的当前数据。